NEU neuren pharmaceuticals limited

Ann: Disclosure under Listing Rule 4.3D, page-59

  1. 388 Posts.
    lightbulb Created with Sketch. 243
    In the past 4 years Neuren has produced its annual report between late March and late April. So we are in the window to expect some more detail in the next few weeks.

    I am hoping they are trying to finalise the deal ahead of this or at least get some indication on what the P3 funding arrangements will likely be. Surely someone wants in!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.10
Change
-0.800(5.76%)
Mkt cap ! $1.629B
Open High Low Value Volume
$13.95 $13.96 $12.88 $9.534M 725.6K

Buyers (Bids)

No. Vol. Price($)
1 266 $13.10
 

Sellers (Offers)

Price($) Vol. No.
$13.15 1619 2
View Market Depth
Last trade - 16.10pm 13/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.